Last week, Brent Saunders participated in a panel discussion on R&D approaches at the Forbes Healthcare Summit in New York City. The Summit brings together the most influential leaders from the healthcare ecosystem, including industry executives, medical professionals, researchers, policymakers and philanthropists to explore key topics facing healthcare today. During the session, Brent had an opportunity to reinforce Allergan’s ongoing commitment to innovation and leadership in key therapeutic areas following the Company’s combination with Pfizer.